Cargando…

Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma

BACKGROUND: Early diagnosis is critical to reduce the mortality caused by nasopharyngeal carcinoma (NPC). MicroRNAs (miRNAs) are dysregulated and play important roles in carcinogenesis. Therefore, this study aimed to identify diagnostically relevant circulating miRNA signatures in patients with NPC....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Wen, Mai, Shi-Juan, Lin, Huan-Xin, Zhang, Mei-Yin, Huang, Jia-Ling, Hua, Xin, Lin, Chao, Long, Zhi-Qing, Lu, Zi-Jian, Sun, Xiao-Qing, Liu, Sai-Lan, Yang, Qi, Zhu, Qian, Wang, Hui-Yun, Guo, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547589/ https://www.ncbi.nlm.nih.gov/pubmed/31159814 http://dx.doi.org/10.1186/s12967-019-1923-2

Ejemplares similares

A Model Combining Skeletal Muscle Mass and a Hematological Biomarker to Predict Survival in Patients With Nasopharyngeal Carcinoma Undergoing Concurrent Chemoradiotherapy
por: Huang, Han-Ying, et al.
Publicado: (2021)

Sarcopenia is associated with higher toxicity and poor prognosis of nasopharyngeal carcinoma
por: Hua, Xin, et al.
Publicado: (2020)

A novel three-microRNA signature for predicting survival in patients with nasopharyngeal carcinoma
por: Zhang, Shan-Qiang, et al.
Publicado: (2022)

Modeling Sarcopenia to Predict Survival for Patients With Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy
por: Hua, Xin, et al.
Publicado: (2021)

Low Skeletal Muscle Mass Impairs Quality of Life in Nasopharyngeal Carcinoma Patients Treated With Concurrent Chemoradiotherapy
por: Hua, Xin, et al.
Publicado: (2020)

Efficacy of controlled-release oxycodone for reducing pain due to oral mucositis in nasopharyngeal carcinoma patients treated with concurrent chemoradiotherapy: a prospective clinical trial
por: Hua, Xin, et al.
Publicado: (2019)

Overexpression of acylglycerol kinase is associated with poorer prognosis and lymph node metastasis in nasopharyngeal carcinoma
por: Zhu, Qian, et al.
Publicado: (2015)

Identification of a 7‐microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection
por: Zhang, Huo, et al.
Publicado: (2019)

M1 stage subdivisions based on (18)F-FDG PET-CT parameters to identify locoregional radiotherapy for metastatic nasopharyngeal carcinoma
por: Qiu, Hui-Zhi, et al.
Publicado: (2022)

Nomogram Predicting the Benefits of Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy After Induction Chemotherapy in Stages II–IVb Nasopharyngeal Carcinoma
por: Liu, Sai-Lan, et al.
Publicado: (2020)

Four-microRNA signature for detection of type 2 diabetes
por: Yan, Li-Na, et al.
Publicado: (2020)

Circulating microRNA signature for the diagnosis of childhood dilated cardiomyopathy
por: Jiao, Meng, et al.
Publicado: (2018)

Whole blood-derived microRNA signatures in mice exposed to lipopolysaccharides
por: Hsieh, Ching-Hua, et al.
Publicado: (2012)

A Five-MicroRNA Signature Predicts the Prognosis in Nasopharyngeal Carcinoma
por: Wu, Shixiong, et al.
Publicado: (2021)

The four-microRNA signature identified by bioinformatics analysis predicts the prognosis of nasopharyngeal carcinoma patients
por: Zhang, Siwei, et al.
Publicado: (2019)

IQGAP3 Overexpression Correlates With Poor Prognosis and Radiation Therapy Resistance in Breast Cancer
por: Hua, Xin, et al.
Publicado: (2021)

MicroRNA-18a promotes cancer progression through SMG1 suppression and mTOR pathway activation in nasopharyngeal carcinoma
por: Mai, ShiJuan, et al.
Publicado: (2019)

MicroRNA-101 inhibits invasion and angiogenesis through targeting ITGA3 and its systemic delivery inhibits lung metastasis in nasopharyngeal carcinoma
por: Tang, Xin-Ran, et al.
Publicado: (2017)

When the Loss Costs Too Much: A Systematic Review and Meta-Analysis of Sarcopenia in Head and Neck Cancer
por: Hua, Xin, et al.
Publicado: (2020)

FNDC3B 3′‐UTR shortening escapes from microRNA‐mediated gene repression and promotes nasopharyngeal carcinoma progression
por: Li, Ying‐Qing, et al.
Publicado: (2020)

The prognosis of neck residue nasopharyngeal carcinoma (NPC) patients: results from a case-cohort study
por: Liu, Sai-Lan, et al.
Publicado: (2018)

Identification of non-invasive biomarkers for predicting the radiosensitivity of nasopharyngeal carcinoma from serum microRNAs
por: Li, Kaiguo, et al.
Publicado: (2020)

Overexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 Patients
por: Liu, Sai-Lan, et al.
Publicado: (2017)

MicroRNA Landscape in Endometrial Carcinomas in an Asian population: Unraveling Subtype-Specific Signatures
por: Tan, Gideon Ze Lin, et al.
Publicado: (2023)

Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Breast Cancer: A Propensity Score-Matching Study
por: Hua, Xin, et al.
Publicado: (2020)

MicroRNAs in nasopharyngeal carcinoma
por: Bruce, Jeff P., et al.
Publicado: (2014)

A three-microRNA panel in serum as novel biomarker for papillary thyroid carcinoma diagnosis
por: Zou, Xuan, et al.
Publicado: (2020)

A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma
por: Zhou, Xin, et al.
Publicado: (2017)

Circulating microRNAs as the Potential Diagnostic and Prognostic Biomarkers for Nasopharyngeal Carcinoma
por: Le, Thuy Ai Huyen, et al.
Publicado: (2022)

Identification of a Circulating MicroRNA Signature for Colorectal Cancer Detection
por: Wang, Jia, et al.
Publicado: (2014)

Differential genome-wide profiling of alternative polyadenylation sites in nasopharyngeal carcinoma by high-throughput sequencing
por: Xu, Ya-Fei, et al.
Publicado: (2018)

Serum microRNA expression profiling revealing potential diagnostic biomarkers for lung adenocarcinoma
por: Shan, Xia, et al.
Publicado: (2020)

Identification of a microRNA signature associated with risk of distant metastasis in nasopharyngeal carcinoma
por: Bruce, Jeff P., et al.
Publicado: (2015)

MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma
por: Liu, Sai-Lan, et al.
Publicado: (2020)

Exosomal MicroRNA signature acts as an efficient biomarker for non-invasive diagnosis of gallbladder carcinoma
por: Yang, Pinghua, et al.
Publicado: (2022)

Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma
por: Liu, Sai-Lan, et al.
Publicado: (2018)

The role of microRNAs in nasopharyngeal carcinoma
por: Tan, Gongjun, et al.
Publicado: (2014)

Regulation of MicroRNAs, and the Correlations of MicroRNAs and Their Targeted Genes by Zinc Oxide Nanoparticles in Ovarian Granulosa Cells
por: Zhao, Yong, et al.
Publicado: (2016)

Identification of an 88-microRNA signature in whole blood for diagnosis of hepatocellular carcinoma and other chronic liver diseases
por: Long, Xiao-Ran, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ga75esj9f1ktotrigrh24shqud